Targeted antibiotic gel helps 80% of pilot patients avoid foot amputation, Jerusalem trial finds
Jerusalem PostGentaGel’s biodegradable treatment releases antibiotics directly at infection sites for up to 60 days; the company is pursuing further trials and an FDA regulatory pathway.
More in this section
- Top Secret Festigal and Motek Forever unveil competing 2026 Hanukkah lineups
- Muslim charity CAIR-NJ's back-to-school guide attributes 9/11 attacks to US support for Israel
- The Mecca Joint Defense Agreement is a looming threat to Israel and America
- Finland, Israel quietly extend defense agreement for 10 years